Jennifer Sasson, MD, Receives National News Coverage for Clinical Trial Using Asthma and Eczema Treatment to Improve Survival of COVID-19

August 25, 2022 by

Jennifer Sasson, MD, head shotJennifer Sasson, MD’s clinical trial indicating a treatment for asthma and eczema may improve survival rate for patients hospitalized with moderate to severe COVID-19 has received widespread national news coverage. Jennifer and her team of UVA collaborators including William A. Petri, MD published their study in the scientific journal Open Forum of Infectious Diseases. 

Read more in UVA Today. 

Original Source

Filed Under: Clinical, Media Highlights, Research